Patients with pulmonary hypertension are al risk of developing total right heart failure after hear) transplaalafioa, to evaluate Ibis risk potential, candidates for heart transplantation are screened by measuring rest right heart pressures and the response to ldlroprusride. To lest the validity of this approach . !I . in°e-ence of pretransplaoation right bean c theteriaatian data on outcome after transplantatlua was amlyred in 29y of 301 eoaceeutive palieats.
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Patients with a pulmonary vascular resistance >2 .5 Wood units measured at baseline studs had a 3-month mortality rate of 17 .9% compared with 6 .9% en patients %ilh resistance 52,5 units (p < 0.02). Patients with a pulmonary vascular resistance X2 .5 units at baseline study could he difereartiated further according to their hemodynamie response to nilroprltsside : these whose resistaace could be reduced to m2 .5 units with a stable systemic systolic Most patients with advanced heart failure under consideration for heart transplantation have at least moderately elevated pulmonary artery pressure . Severe pulmonary hype-tension is considered a contraindication to orthatopic transplantation because of the risk of acute right ventricular failure when the right ventricle of the grafted heart is unable to adapt to significant pulmonary hypertension in the immediate postoperative period (1-3). Recently, several studies (4-6) have confirmed that elevated pulmonary vascular resistance is an independent risk factor for mortality both early and late after trans ;9lanlation .
However, some patients with moderate to severe pulmonary hypertension have successfully indergone transplants' Lion . In these patients, serial hemodynamic measurements after transplantation detnohstrated a progressive decrease in pulmonary artery pressure, illustrating the potential rcvera. ibiliity of pulmonary hypuntettsiun pressure -85 mm Hg had a 3-month mmtall!} rateofonty, 3 .8%. In coataan, patients whose pulmonary vaseolvr resistance could unit he reduced to <2.5 units, and those whose resistance could be reduced to 52,5 units but only at the expense of systemic hypotensioo (systoic pressure <85 mm Hg) had a 3-mouth mortality rate of *.6% and 27.5%, respectively. Furthermore, all 10 patients who died of right heart failure belonged to the latter two groups.
These findings confirm the value of right heart benadynamic measurements and the response in ntlropru side In predicting early mortality after heart transplantation and, in particular, .rnrtality due to right heart failure. Valid risk stratification based on the nemodynamic response to nitroprusside requires consideration of the concomitant change in systemic pressure .
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hypertension by administration of 1009 oxygen, nitreglyc crin or nitroprusside is frequently performed in evaluating candidates for heart transplantation (6, (13) (14) (15) . However, no systematic study has been performed of whether then, maneuvers aid in assessing the risk of acute graft right bean failure and the attendant early mortality after transplantation. Al Stanford . candidates for heart transplantation undergo right heart catheterization and, for those with elevated pulmonary vascular resistance or systolic pulmonary pressure, or both . an attempt is made to evaluate the reversibility of pulmonary hypertension with a graded nitroprusside infusion. The data obtained have been reviewed and retrospectively analyzed in 393 of 301 consecutive transplant recipioots to evaluate the relation between right heart hemody nannies . response to nitroprusside and outcome after heart transplantation .
Methods
Study patients. Between December 1980 (when cyclosporine was introduced to the immunosuppressive regimen) and July 1999, 301 New York Heart Association functional class IV patients underwent heart transplantation at Stanford University Medical Center . The patients (231 men and (719.Iron,sot53 10 70 women, ranged in age from 9 months to 60 years (mean 39 4 years). The primary diagnosis was cardiomyopathy in '54 patients, end-stage left ventricular failure from coronary artery disease in 112, congenital heart disease in 13, postpartum cardiomyopathy in 6 . valvular heart disease in 4 . adriamvcln-induced cardiomyopathy in 3, rstrictise hewn disease in 3, sarcosdosis in 2 . acute n:vocarditis in 3 arid amvloidosis in I .
Right heart catheteriratiun, Two hundred ninety-three of the 30! patients underwent rigbl heart cathe:,-rization in the catheterization laboratory at Slaniord Umceroy Hospfmt : under fluoroscopic guidance, a 7F balloon flotation pulmonary artery catheter was advanced to the pulmonary occlusive position (usually by way of the ju€ular vein) . A cannula inseried into a brachial or radial artery was used for systemic pressure recordings and for repeated arterial blood sampling . Micron transducers were used to record an a Hewlett Packard recorder these pressures (in mm tlgr mean right atria, ; pulmonary artery systolic, diastolic end mean (PAP mean); pulmonary capillary wedge (PCWP) ; and systemic arterial systolic, diastolic and mean pressures . Cardiac output (CO) was measured by the Fick method nd normalized for body surface area (cardiac i ndex. C U .
Pulmonary Patients with pulmonary vascular resistance >2 .5 units or systolic pulmonary artery pressure >40 mm lig . or both . received a graded nitroplssside infusion to evaluate reversibility of pulmonary hypertension .
Nitroprusside infusion . An intravenous nitroprussidc in . fusion was started at a dose of 25 to 50 oglmin . The dose was increased rapidly and hemodynamic measurements were obtained during the 5th min after every dose increase . uhtil there was a clinically significant reduction in mean arterial pressure or a reduction of pulmonary vascular resistance to =2 .5 units and a reduction of systolic pulmonary artery pressure to <40 mm Hg . For repeated determinations cf cardiac output, only arterial and mixed venous blood samples were collected serially; oxygen consumption was routinely calculated from results of an expired gas collection at baseline study .
Evaluation of catheterlratinn data and Correlation with efinfeal course . Catheterization data obtained before transplantation, including hemodynamin response to nilroprus- • Rniec±Ion • sitters Figure 1 . Cause of demh in the tsl 3 months alter heart transplantation in 301 consecutive patients CVA = cerebrovascular ancidem : PF = pulmonary embolism ; PHT = pulmonary hypertension : RHF = ngha heap failure .
side infusion, were reviewed and correlated with the patient's clinical course after transplantation . Analysis included incidence of early postoperative mortality (defined as death =90 days after transplantation) and presence or absence of significant right heart railure. Postoperative right heart failure was defined as significant when pulmonary vasodilators were required in conjunction with clinical evidence of right ventricular dysfunction and failure . A cause of death was assigned to each patieot who died after transplantration . Whenever possible, the assigned cause of death was based en autopsy findings; when these were not available, it was based on all available clinical and laboratory data .
Results
Survival rates and causes of death (Fig. I) . Of the 301 patients, 39 died within 90 days, 7 died within 3 to 6 months and 12 died within 6 to 12 months after heart tmnsplantalbn, corresponding to a survival rats of 86 .7%, 84.4% and 80.4% at 3 . 6 and 12 months, respectively . after transplantation . The most common cause of early (090 days) postoperative death was infection, accounting for 43 .6% of deaths, to[-lowed by acute rejection (15 .4% of deaths) . Twenty-six percent of the deaths were due to pulmonary hypertension or right heart failure, corresponding to an overall mortality rate due to pulmonary hypertension or right heart failure of 3.3% (10 of 301 patiene0.
Clinical right heart failure. In addition to the patients who died of irreversible right bean failure or pulmonary hypertension. 10 patients had a postoperative course complicated by clinical signs of right heart failure, necessitating prolonged inotropie and vasodilator support given intravenously . Four of these patients were successfully treated with prostaglandin E ; another four died 590 days after transplantation because of infection. Preoperative right heart hemodynamirs at baseline study (Table 1) . Right hears calhelenzation was performed in 293 patients. Five of these patients (including one "bodied early after transplantation because of right heap failure) were dependent on intravenous isotropic support at the lime of preoperative evaluation. so that no true baseline data for nitroprusside were available . The baseline hemodynamic data in the remaining 288 patients are summarized in Table I . Cardiac index ranged from 0 .4 to 5 literslmin per m2 (mean 2 0.8).
Pulmonary vascular resistance ( Table 2 ) . The pulmonary vascular resistance, calculated in Wood units, ranged from 0.2 to 13 .41 mean 3 .2'-2 .11 . Figure ? shows the distribution of baseline values for pulmonary vascular resistance in relation to 3-month mortality . Table 2 summarizes the outcome for transplant patients according to different threshold values . A total of 145 (50,4%) of 288 patients had a baseline pulmonary vascular resistance value >2 .5 units . Of these patients, 26 I17,91e) died 2690 days after transplantation, compared with In (6.99c) who died early postoperatively among 143 patients with a baseline pulmonary vascular resistance w2.5 units (p < 0 .02). All 9 patients who died early after transplantation of pulmonary hypertension or right heart failure, as well as all 10 patients who developed right heart failure postoperatively but survived, had a baseline pulmonary vascular resistance >2 .5 units. A higher pulmonary vascular resistance threshold ( .85 vs . >5 resistance units and O8 vs . >8 units) revealed a higher percent of early postoperative deaths in the groups with higher values (I I deaths [22,9551 in 48 patients with a resistance level >5 units and 2 deaths [22 .241; in 9 patients with a resistance level >8 units). However, among the nine patients who died of right heart failure, six had a pulmonary vascular resistance 55 units and all nine had a level 58 units, demonstrating loss of sensitivity if the pulmonary vascular resistance threshold was set higher than 2 .5 units .
Pulmonary vascular resstance index . This index ranged from 0 to 28 .9 resistanre index units (mean 5 .7 ± 3 .8) . this value. PHT = pulmonary hypeneosion : Pis. = patients : RHF = tight loran failure . Other abbreviations and units as in Table 1 .
Among 130 patients with a pulmonary vascular resistance index >5 index units, 23 died 090 days after transplanlatien . The mortality rate of 17 .7% is significantly higher (p < 0,05) than that of the 8.6`, (13 deaths) in the 151 patients with a pulmonary vascular resistance index _5 index units . Two of the nine patients who died w90 days after transplanla0on as a result of pulmonary hypertension or right heart failure had a pulmonary vascular resistance index <_5 index units and all nine patients with clinical right heart failure belonged to the group with a resistance index s5 index units . Data far patients with an index 08 versus >8 index units were also examined. The mortality rate in the group with the higher index (10 deaths among 56 patients, 17 .9%) was sdnitar to that obtained in the group with the higher index as defined by a pulmonary vascular resistance index of >5 or ea5 index units. However. the upper threshold of 8 resistance units failed to include seven of nine patients who died of pulmonary hypertension or right heart failure and three of nine patients with postoperative right heart failure, all of whom had a pulmonary vascular resistance index =8 units . Baseline PVR Figure 2 . Influence of baseline pulmonary vascular resistance (PVR) values an }month mortality after heart iamplantstion studied bas = patients who died within 3 months after transplartation : sml(d bars = patients who survived -3 months, patients . 23 died <90 days after transplantation, which is a significantly higher mortality rate (!7%l than that in the group with a systolic pulmonary artery presdoh =50 mm Hg (8.3%, p < 0 .05) . Among the 9 patients who died of pulmonary hypertension or right heart failure . I patient had a systolic pulmonary artery pressure =5O mm Hg, as did 3 of 10 patients with postoperative right heart failure . A higher threshold of 60 mm Hg revealed a higher early posoperative mortality rate in patients with an elevated pressure (24 .6%) : however, 6 of 9 patients who died of pulmonary hypertension or right heart failure and 5 of 10 patients with pastuperative right heart failure had a systolic pulmonary artery pressure s00 mm Hg . The franspulmonary gradient ranged from 0 to 37 mm Hg (mean 10 ± 6). A threshold of 15 mm Hg separates the groups at low and high risk for early postoperative mortality (transpulmonary gradient <I5 mm Hg ; 3-month mortality rate 11 .3% vs. transpulmonary gradient >15 mm Jig, 3-month mortality rate 20%; p < 0 .02). However . measurement of the transpulmonary gradient did not differentiate between patients at risk of death from pulmonary hyperten . sion or right heart failure early after transplantation ; there Hemodynamic rote-to nitroprusside fl'able 3) . A total of 150 patients received nitroprusside infusion ; 135 had a pulmonary vascular resistance >2 .5 units and systolic pulmonary artery pressure >40 mm Hg, 10 had systolic pulmonary artery pressure >40 mm Hg and a pulmonary vascular resistance`-2 .5 and 5 patients were dependent on a low dose of nitroprusside given intravenously at preoperative catheterization and therefore no baseline data were available . Patients were divided into three groups according to their hemodynamic response to nitroprusside (Table 3 ) . Group A consisted of 32 patients whose pulmonary vascular resistance could not be decreased to <2 .5 units; Group B consisted of 40 patients whose pulmonary vascular resistance could be lowered to s2,5 . but only at :he expense of severe systemic hypotension (systolic arterial pressure s85 mm Hgi and Group C consisted of 78 patients whose pulmonary vasctdar resistance could be lowered to <-2.5 without concomaant severe systemic hypotension . maintaining a systolic arterial pressure e85 mm Hg. Among the 78 Group C patients who showed reactivity of pulmonary hypertension . only 3 (3 .8%) died ±90 days after transplanlarian . In contrast . 11 patients (27.5%) in Group B and 13 patients (40 .5P01 in Group A died. Moreover, all patients who died of right hart failure or pulmonary hypertension belonged to Group A (3 of 32) or Group B (7 of 40) . In addition . all patients who developed but survived posloper .save right heart failure were in Group A (n = Ill or B in = 2) .
I(frenmdraamic data at baseline study and the data after nirrapruusisr infusion are summarized, the s,rtnbincd data can be used to drone two groups (Fig . 3 ) : patients at high and patients at considerably lower risk of death early after transplantation . Patients at high risk included those whose pulmonary vascular resistance could not be decreased to <2 .5 units with nitroprusside (Group A) and those in whom such a decrease was achieved only al the expense of severe systemic hypoteasion (Group B). Patients at lowerri5k were those who '-hocred a signtfieanm reduction in pulmonary vascular resistance but maintained stable systemic pressure after nitroprusside infusion (Group CI and these whose baseline pulmonary vascular resiltanee was m .5 units and Early poswperatisu --r compliu>rd by st :ceol right he ,e Oiture . Abbrcviatiun, end units as in Tables I and 2 Figum 3. Thrcc•I aonlh mortality after transplantation : dificrentiatioa of low and high risk groups according to pienperalivc pulmonary hypertension. Group A = patients whnse pulmonary vascular resistance could no[ be decreased to <2S Wood units in = 32): Group 9 -patients whose pulmonary vascular re.si .stance could be reduced to <2 .5 Wood units at the expense of severe systemic hypotensidn in = 40) ; Group C = patients whose pulmonary vascular resistance could (n = 78) be loweted to <_2 .5 units without severe systemic hypotension : Group D -patient, whore pulmonary vascular resi.+lance was <2 .5 units at baseline. Other abbreviations as in Figure I . Hitched liars = deaths due to right heart failure and pulmonary hypertension ; solid ban = deaths due to other causes .
did pool receive nitroprusside (Group Dl . The high risk group had a five to six times higher early postoperative mortality rate (33 .3 vs . 6%; p < 0,OW1). Font'-t .vo percent of deaths in the high risk group (10 of 24) tsars due to pulmonary hypertension or right heart failure resulting in an mortality rate due to right heart failure or pulmonary hypertension of 13 .9'* in ibis group . Moreover, an additional 15% of these high risk patients developed, but survived, postoperative right heart failure . Trlble 4 compares clinical data aid herrrodvnamie 'ariaHer is thaw rn o groups ifparienrs. There were no 50405ti-cally significant differences between the high and low risk groups in recipient or donor age and gender, ischemic time, wailing lime for transplantation, .donor.recipient a eight mis . match and diagnosis . .A statistically significant I . :gher percent of patients at high versus low risk were debcndent on intravenous inotrapic support before transplaoth.ion, reflecting the overall poorer preoperative condition of patients in the high risk group. Patients in the high risk group had statistically significant higher values for systolic and mean pulmonary angry pressure, pulmonary vascular resistance and index . Iranspulmonary gradient and systemic arterial systolic pressure. However . there was significant overlap in values between the high and low risk groups . Therefore, differentiation between patients at t :gh and low risk based on the henlodynamic response ant nitroprusside infusion cannot be predicted from baseline hemedyntlmics alone . Some patients in the low risk group had a baseline pulmonary vascular resistance as high as 13 .4 units that could be lowered to <2 .5 units while stable systemic ptesserm was ' No sopporstimravev0us supponlimmaortic batten rump or left v0Rneular chid 4ruirn ICoornery artery discaseiidiopolhic choice ca*divmyopathyrcongenital hear direawhthcr . PordiEeremintion trlaren high hod Irisk groups. See Figure 3 . Abbteuiations as in Table I . maintained, whereas some patients had a baseline pulmonary vascular resistance as low as 2 .7 Lairs that could not he de-creased without systemic pressure compromise .
Discussion
Elevated pulmonary vascular resistance told prisittransplan. Lotion mortality . Resistant pnlmnnary hypertension has long Leon identified as a major cause of early mortality (1-31 . all-rough this concept has only mcentI been systematically evaluated . Kirklin ct at . (51 anaryaed the outcome in 63 patients who vat l racnl heart transph,mation r' ' found an elevated pulmonary vascular resistance (a be the most important risk factor for both catty and tale mortality . Our data confirm the importance of assessing baseline heotodynamics: patients with a baseline pulmonary' vascular resislance >2 5 units have an approximately twofold greater risk of dying -90 days postoperatively . compared wah patients with a pulmonary vascular resistance °--' .5 unhs at baseline study . Furthermore, till patients who died of pulmonary hypertension or right hen,', failure early after transplantation, as well as all sot . . tug patients whose early pos:opeealive course was cotnalicatad by right heart failure . had a pulmonary vascular resistance >'.'s units . However . an elevated baseline pulmonary vascular resistance does not preclude a successful outcome after Iransplantation-Of 145 patients with pulmonary vascular resistance 02 .5 units . I 11) survived the early postoperative period . The accuracy of baseline pulmonary vascular resistance in duterentialing between low and high risk patients could not oe improved by changing the crilic'd resistance threshold. Thresholds >2 .5 units revealed a higher percent of patients wi':; :n elevated pulmonary vascular resistance who died early after operation Ithat is . the higher thresholds yielded greater specificity in detecting patients at risk of premature death) but sensitivity was reduced . Several patients who died early after transplantat ion of right heart failure or pulmona, y hypertension or developed clinical right, heart failure postoperatively had a baseline pulmonary vascular resistance below a threshold of 5 or 8 units .
6ksated pulmonary vascular resistance versus pulmonary hwpertension-h was recently suggested that use of a pulmonary vascular resistance index, which corrects for individual variations in size, as a treasure of pulmonary hypertension or use of the transpulmanary gradient might be superior in identifying patients at risk of premature death after transplantation 10,15) . These findings could not be confirmed by our data ; we did find that a pulmonary vascular resistance index with a threshold of 5 index units, a transpulmonary gradient with a threshold of 15 mm Hg at a systolic pulmonary artery pressure with a threshold of 50 mm Hg also allowed identification old group of patients with significantly increased risk of early mortality, but with a specificity no higher than that of pulmonary vascular resistance . Moreover, a pulmonary vascular resistance with a threshold of 2 .1 units identified all 9 patients who died of right heats failure r(1STARI7-JACKLEANtFOWLER 53 Pt I k10vAtY HYPERTFssioN unit HEARr'ruANSPLANTATh1N and till IU o vieOIs who developed clinical right heart failure peatupuatively . whereas use m"a pulmonary vascular resistance index !threshold 5 units), the transpatmenary, gradient Ithreshold IS mm lie) or the systolic pulmonary artery pres,ur: threshold 50 mm Hgl dtsl nut idoatify sortie patiunts who had values below the threshold but who died of or developed right heart failure early ptetopuratively . Thus, our data indicate that pulmonary vascular resislanee with a threshold of 2 .5 antis identifies patients at high risk of early postoperative death with an accuracy similar to that of [he alternative hasetinr measures of pulmonary hypertension.
hut i, superior in specifically identifying those at risk of death from right heart failure postoperatively and therefore should he used preferentially for this assessment .
Role of hemodynamic response to nitroprusside in eslimat • ing risk of transplantation . The potentia: of nitroprusside m reduce pulmonary hypertension has long been known (16) (17) (18) . As early as 19'71 it was suggested (1) that the hemodyresponse to nitroprusside could be used to differen . riutt between fixed and reversible pulmonary hypertension, selecting patients with pulmonary hypertension for transplantation . and since then, vasodilator studies (3,13) have been recommended as a potentially useful tool in selecting candidates far transplantation. Our analysis confirmed the utility of die hemudynamic response to nitroprusside in estimating the risk of transplantation in patients with elevated baseline pulmonary vascular resistance . We found that the hemalynamtc response to nitroprusside identified paitents at high risk of It dying early after transplantation 13-month mortality rate . 33.3%1 ; 2) dying early after operation of right heart failure (13 .9%) ; and 3) developing right hcarr taaIuer after operation 115%) . Patients at risk include those whose pulmonary vascular resistance could not be reduced to <2 .5 units and also those whose pulmonary vascular resistance could be reduced to <l .5 Units only at the expense of severe systemic hypotension (systolic pressure <85 mm Hg) . These findings highlight the importance of considering the concomitant change in systemic pressure when interpreting the hentalynamic response to nitroprusside .
Conversely. the hemodynamic response to nitropruside could also be useful in identifying a low risk group . FHtienl•: whose pulmonary vascular resistance was reduced with nitroprusside to <2 .5 units while a stable systolic pressure a85 mm Hg was maintained had an overall early posnoperative mortality rate of only 3 .8%, and can therefore be classified as having a risk of early postoperative death as low as that of patients with normal pulmonary vascular resis . tance at baseline study .
Some patients with a baseline pulmonary vascular resistance as high as 13 .4 units responded fully to nitropniesai . whereas the only mildly elevated pulmonary vascular resismnce in others did not change. These data demonstrate that response to nitroprusside, and thus potential reversibility of n1dmnnary hypertension, cannot be predicted from baseline data .
The cause oft he higher rate among patients with pulmonary hypertension of early postoperative dealt caused by factors other than right heart failure or pulmonary hyperien . lion is not clear . Many of these patients' general failure to thrive may increase the susceptibility to fatal infection . Preoperative pulmonary hypertension was recently been reported (t2,16) to he a risk factor for posttransplanlation pulmonary infection . In our study, 4 of the 10 patients who developed significant right heart failure postnperatively died of infection s90 days after transplantation .
Prophylactic treatment . Our study did not include any patients who had heterotopic heart transplantation . The benefit of such treatment to patients with pulmonary hypertension was recently questioned (12) . and overall survival rates reported in the registry of the International Society for Cardiac Transplantation are generally worse than those for anhulopic transplantation . Prostaglandin E I has been used successfully to treat lire-threatening postoperative pulmonary hypertension in patients unresponsive to standard therapy (19, 201 , and its value in reducing perioperative and postoperative mortality is now being studied . If these results are promising + prophylactic treatment of patients at high risk ofdeveloping . right hear failure in the perooperative and early postoperative periods might he beneficial .
Conclusions. Our data confirm the utility Itfaicasurement of right hears hemodynamic variables in the evaluation of risk in candidates for heart transplantation. Our data do not indicate how many patients rejected for cardiac transplantation on the basis of more severe pulmonary hypertension might have fared had they undergone cardiac transplanta-(ion. But they show that even among patients whose pulmo' nary hypertension and responsiveness to nitroprusside were considered acceptable for treatment with beat[ transplonmtion, there was a clear relation between preoperative hemodynamic data and sabsegm^nt early morbidity or mortality .
